We performed genome-wide analysis of copy-number changes and loss of heterozygosity (LOH) in Barrett's esophageal adenocarcinoma by single nucleotide polymorphism (SNP) microarrays to identify associated genomic alterations. DNA from 27 esophageal adenocarcinomas and 14 matching normal tissues was subjected to SNP microarrays. The data were analyzed using dChipSNP software. Copy-number changes occurring in at least 25% of the cases and LOH occurring in at least 19% were regarded as relevant changes. As a validation, fluorescence in situ hybridization (FISH) of 8q24.21 (CMYC) and 8p23.1 (SOX7) was performed. Previously described genomic alterations in esophageal adenocarcinomas could be confirmed by SNP microarrays, such as amplification on 8q (CMYC, confirmed by FISH) and 20q13 or deletion/LOH on 3p (FHIT) and 9p (CDKN2A). Moreover, frequent gains were detected on 2p23.3, 7q11.22, 13q31.1, 14q32.31, 17q23.2 and 20q13.2 harboring several novel candidate genes. The highest copy numbers were seen on 8p23.1, the location of SOX7, which could be demonstrated to be involved in amplification by FISH. A nuclear overexpression of the transcription factor SOX7 could be detected by immunohistochemistry in two amplified tumors. Copy-number losses were seen on 18q21.32 and 20p11.21, harboring interesting candidate genes, such as CDH20 and CST4. Finally, a novel LOH region could be identified on 6p in at least 19% of the cases. In conclusion, SNP microarrays are a valuable tool to detect DNA copynumber changes and LOH at a high resolution. Using this technique, we identified several novel genes and DNA regions associated with esophageal adenocarcinoma.
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The incidence of esophageal (Barrett's) adenocarcinoma, mostly arising within the precancerous Barrett's esophagus, with the normal esophageal squamous epithelium changed into intestinal metaplasia, has risen in the past decades in western countries. 3 Screening for chromosomal alterations has been performed to identify potential markers for development and progression of Barrett's carcinoma. Two techniques of comparative genomic hybridization (CGH), metaphase CGH (mCGH) [4] [5] [6] and array CGH (aCGH) 7 Both methods are complementary in characterizing chromosomal aberrations but they are limited to the detection within a range of 1-20 Mb. 8 Another disadvantage is that LOH can be detected only indirectly if it is caused by deletion of one allele. The single nucleotide polymorphism (SNP) array technology, which has originally been developed for allelotyping and linkage analyses, allows a genome-wide fine mapping of copy-number changes within a range of 30-900 kb. In addition, the genotypes of the SNPs provide information about LOH throughout the genome. Regarding the copy-number changes in LOH loci it is possible to distinguish different mechanisms leading to LOH detection, such as deletion, mitotic non-disjunction or monoallelic amplification. 9 Recently, the technique was used to investigate the progressive genomic instability in biopsies of preinvasive lesions of six patients with Barrett's esophagus, revealing interesting alterations in premalignant stages. 10 We applied the SNP array technique to 27 invasive esophageal adenocarcinomas and 14 matched normal tissues for a genome-wide detailed view of copy-number changes and LOH.
MATERIALS AND METHODS Subjects and Tissues
Frozen esophageal adenocarcinoma samples of 27 patients (24 men, 3 women) and 14 matched non-neoplastic samples of unaffected esophageal squamous epithelium were analyzed. All carcinomas have been primarily resected without preoperative radio-or chemotherapy. Histological tumor typing as proposed by the WHO classification schemes 11 revealed moderately or poorly differentiated adenocarcinomas of the distal esophagus in all cases. The tumors were staged according to the International Union against Cancer (UICC):
12 stages pT1, pT2 and pT3 were represented and lymph node metastases occurred in 20 of 27 patients (74%) ( Table 1 ). The snap frozen samples were cut serially into 10-mm sections and 2 Â 20 mg of each were collected in two 1.5-ml tubes. Each first and last section (5 mm) was stained with hematoxylin and eosin for histologic control to assure a relative tumor cell content of at least 70%.
DNA Extraction, Sample Processing and Array Hybridization DNA was isolated using Qiagen DNeasy Tissue Kit (Qiagen, Hilden, Germany) following the manufacturer's instructions. DNA quality and yield of all samples were assessed by the ratios of absorbance at 260 and 280 nm and by agarose gel electrophoresis (0.7%).
Further sample processing, including digestion, adaptor ligation, amplification, fragmentation, labeling, hybridization and scanning was assayed according to the standard protocol (Affymetrix GeneChip Mapping 10K 2.0 Assay Manual). Briefly, 250 ng genomic DNA of each sample was restricted with XbaI before adaptor-ligated PCR amplification. After purification from free primers and nucleotides, the PCR products were checked by agarose gel (2%) electrophoresis and quantified spectrophotometrically. The purified PCR products were fragmented, labeled with biotin, added to a hybridization solution and hybridized to the 10K 2.0 Mapping Array (Affymetrix, Santa Clara, CA, USA). This array contains complementary probes of 10 204 biallelic SNPs, which are located within the amplified 250-1000 base XbaI fragments. For each probe, both the sense and antisense Data Analysis CEL files, containing intensity value and standard deviation for each probe on the chip were generated for each array using the GeneChip Operating Software (Affymetrix). Perfect match-mismatch average difference intensities as a signalto-noise value and the genotypes (AA, AB and BB) were calculated for each biallelic SNP using the GeneChip DNA Analysis Software (Affymetrix). The signal detection rate, which shows the percentage that pass the discrimination filter, and the percentage of SNPs called on the array-the call rate-were determined for each array. For further data analysis and illustration of the results, the CEL files were imported into the dChipSNP module 13 based on the dChip software.
14 All arrays were normalized to the array of median average intensity. Using a model-based method, the signal values for each SNP in each array were calculated. For copy-number estimation, signal values of each SNP locus of the tumor samples were compared to a set of 14 normal tissue samples, which were defined to have two copies per cell in all loci. A calculated copy number of more than 3 and less than 1.25 was scored as copy-number gain and loss, respectively. The total numbers of gains and losses per case were correlated with the primary tumor (pT) stage, the nodal status (pN) stage and the tumor grading (G), followed by statistical evaluation using the Student's t-test. A copynumber change was regarded as frequent and listed in Table 2 or 3, when occurring in at least 25% of the cases.
For LOH analysis, the software scored the LOH events with regard to the different informative marker densities in different chromosome regions. The LOH scores were then mapped to chromosome regions for each sample and a curve of the prevalence of LOH across all samples, calculated as average probability of LOH by a hidden Markov model based on the genotype calls. For each case, the LOH regions detected by this method were then reviewed in the results of copy-number analysis for differentiation between LOH, deletion and amplification, as for example, monoallelic amplification can lead to LOH detection due to a relative preponderance of the amplified allele. As non-neoplastic esophageal mucosa of 14 cases was available, manual matched pair analysis (SNP by SNP comparison of allelotypes) was performed to detect further (smaller) LOH regions. If in at least one SNP a homozygous call was seen in a tumor sample, which had a heterozygous call in the corresponding non-neoplastic sample, the locus was regarded as LOH (see exemplary illustration for chromosome 9 in Figure 1 ).
Retrieving annotation information about the SNP loci was carried out by using online databases NetAffx (http:// www.affymetrix.com), Ensembl (http://www.ensembl.org) and Gene Ontology (http://www.geneontology.org).
The number of LOH loci per case was correlated with the pT, pN and the grade of differentiation (G).
Fluorescence In Situ Hybridization Fluorescence in situ hybridization (FISH) analysis was performed using a combination of three clones (RP11-49I23, RP11-593D05 and RP11-1082H13) for visualization of the SRY (sex-determining region Y)-box 7 (SOX7) gene region labeled with FITC-dUTP (green fluorescence), a locus-specific probe for CMYC, labeled with Cy3-dUTP (orange fluorescence) and a centromere probe 8 (CEP8), labeled with DEACdUTP (aqua fluorescence) (Chrombios, Raubling, Germany). Paraffin slides of 10 cases were available for FISH analysis.
Paraffin was removed from tissue sections (8 mm) by xylene (30 min) and isopropanol (3 min) and the slides were hydrated in a graded series of ethanol (100, 96, 70 and 50%) and PBS (pH 7). After pretreating the slides for 20 min in a microwave oven (180 W) in citrate buffer (pH 6) and pronase E (0.05%) digestion for 2 min at 371C, they were washed in PBS for 2 min and dehydrated over a graded series of ethanol (70% for 2 min, 90% for 2 min and 100% for 2 min). Then the slides were air dried and denatured in 70% formamide (10 min, 731C) before the FISH probes were added for 48 h at 371C. After hybridization, the slides were placed in 2 Â SSC/ 0.1% NP-40 (pH 7.4) at 731C for 2 min, nuclear counterstaining with DAPI (10 min) was performed and the slides were embedded in antifade solution (Vectashield).
Fluorescence images were acquired using a Zeiss Axioplan2 imaging microscope (Carl Zeiss Jena, Jena, Germany) equipped with a PlanApochromat X63/NA1.4 oil objective lens and the ApoTome (Carl Zeiss Jena). The numbers of CEP8 per cell, MYC per cell and SOX7 per cell were determined by evaluating at least 30 cells per case.
Immunohistochemistry
In five cases, paraffin slides were available for immunohistochemical staining. Slides (3 mm) were pretreated in a steamer for 30 min (pH 6). Staining was performed using an anti-human SOX7 goat antibody (R&D Systems, MN, USA, diluted 1:50) and the streptavidin/AP system with biotinylated rabbit anti-goat antiserum (1:200) in an autostainer plus (Dako, Glostrup, Denmark) according to the Dako standard protocol. Nuclear and cytoplasmic staining intensity was semiquantitatively graded as negative (0), moderately positive ( þ ) or strongly positive ( þ þ ).
RESULTS

Quality Parameters and Overall Frequency of Genomic Changes
The mean genotyping call rate was 82.28% and the mean signal detection rate was 91.84%. As an estimation of the Genetic alterations in Barrett's carcinoma T Wiech et al genotyping accuracy, there were 0.52% heterozygous SNP calls on the X chromosome of all male patients (tumor and normal tissue). Copy-number changes occurred in all 27 carcinomas (100%) and LOH, detected by scoring, was seen in 20 of 27 cases (74%).
Copy-Number Changes
Using the high-density Affymetrix 10K 2.0. Mapping array for the detection of genomic imbalances in 27 cases of Barrett's esophageal adenocarcinoma, our data confirmed previously published data as determined by mCGH 5, 6 or aCGH. 7 As summarized in Table 2 , highest frequency of copy-number gains was seen on 2p23.3 (ALK; 44%), 7q11.22 (WBSCR17, CALN1; 48%), 13q31.1 (SOX1; 44%), 14q32.31 (SLC25A29; 44%), 17q23.2 (LRRC37A3; 52%) and 20q13.2 (CBLN4; 44%). The highest levels of amplification were detected on 8p23.1 (SOX7, GATA4; maximum copy number (maximum CN) 21.4), 8q24.13 (MYC, FAM84B; maximum CN 19.7), 12p12.1 (SSPN; maximum CN 14.6) and 19q12 (ZNF536; maximum CN 12.7).
As illustrated in Figure 2 , the highest copy-number gain with up to 21.4 gene copies, as calculated by dChip software, was seen on 8p23.1. The least common amplified region of the seven involved cases was represented by the SNP_A-1508297 on position 11 054 000 bp and SNP_A-1513639 on position 11 422 000 bp. The amplified region harbors several candidate genes, such as SOX7 and GATA4.
Correlation of the numbers per case of loci showing DNA gains revealed a tendency of pT2 tumors having more amplifications than pT1 tumors. However, as we investigated few cases and there were only two tumors classified as pT1, this tendency was not statistically significant. Correlation with the pN and grading (G) did not show significant changes.
Highest frequency of copy-number losses was seen on 3p14.2 (fragile histidine triad (FHIT), LOC131691; 48%), 9p21.3 (KIAA1797, PTPLAD2, CDKN2A/p16; 59%), 18q21.32 (CDH20, LOC731576; 41%) and 20p11.21 (CST4; 41%) as shown in Table 3 .
There was no significant correlation of deletions with pT and pN categories or histological tumor grade. Recurrent DNA copy-number gains occurring in at least 26% (7/27) of the cases. Candidate genes of the amplified regions are listed with their molecular function and referenced when previously described in BCA.
Genetic alterations in Barrett's carcinoma T Wiech et al LOH Copy-number losses were often associated with LOH and the highest frequency of LOH (Table 4) was detected on 4q31.22-qter, 5q14.2-35.1, 6p25.1-pter, 7q35-qter, 9p, 11p13-p14.3, 13q21.33-qter, 17p12-pter, 17q21.32-q24.2 and 18q22.1-qter. Many LOHs, found by LOH scoring, were large chromosomal regions, involving whole chromosome arms or even whole chromosomes, indicating that many of these LOHs were due to large deletions or monosomy. On chromosome arm 9p, a known region of high LOH frequency, only six tumors (22%) showed an LOH detected by scoring (Figure 1 ). To detect smaller LOH regions, manual comparison of allelotypes of tumor tissue vs non-neoplastic tissue was performed in 14 cases, in which sufficient uninvolved tissue was available. This analysis revealed several additional genomic LOHs, as listed in Table 4 ('matched pair analysis', italic). Regarding the 9p region, the LOH frequency raised up to 64% (9 of 14 matched pair cases) when manual SNP by SNP comparison was performed.
Correlating the total numbers of LOH loci with the pT stage, the pN stage and the G did not show significant differences.
FISH
For validation of the detected copy-number changes, we chose the two frequently amplified regions on chromosome 8: 8q24.21, the location of the previously identified MYC gene and 8p21.3, harboring the novel candidate gene SOX7. For visualization, we designed a combined FISH probe for MYC, SOX7 and centromere 8, which was hybridized on slides of 10 carcinomas. A nearly normal copy number of MYC could be confirmed in case 9, a low-level gain was confirmed in six cases and a higher level amplification was confirmed in case 15 (Table 5 ). In contrast, in cases 14 and 17, a low-level copynumber gain, seen in FISH analysis, was not detected by SNP arrays. High-level amplification of SOX7 could be confirmed in all three cases examined (7, 13 and 15) and nearly normal copy numbers of SOX7 were detected in five cases by both SNP arrays and FISH analysis. In contrast, a reduced copy number of SOX7 in case 14, as detected by SNP array, could not be confirmed by FISH. In two cases, which had normal copy numbers in SNP array analysis, FISH revealed slight copy-number gains due to polysomy (cases 1 and 17). Frequent DNA copy-number losses occurring in at least 26% (7/27) of the cases with candidate genes and their molecular function. References are given for genes published to show losses in BCA.
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Immunohistochemistry
As shown in Table 5 , immunohistochemistry of five available cases revealed nuclear staining of two SOX7-amplified tumors and nuclear negativity of two non-amplified tumors. However, one non-amplified tumor (case 1) also showed weak nuclear positivity. Cytoplasmic staining was seen in three cases (two amplified and one non-amplified tumor). The results of comparative array, FISH and immunohistochemical analyses are summarized in Table 5 and representative images of FISH and immunohistochemical staining of cases 7 and 14 are shown in Figure 3 .
DISCUSSION
In this first report of combined screening for copy-number changes and LOH using SNP oligonucleotide microarrays in Barrett's adenocarcinoma, we were able to confirm many known genomic alterations. In addition, we could identify several novel altered DNA regions.
In concordance with published data, we found a DNA loss on chromosome band 3p14.3 (48% of our cases), where the FHIT gene is located. Frequent deletions of FHIT (55% of the cases) and aberrant transcripts (93% of the cases) have been described in Barrett's adenocarcinoma before. 18 However, the role of FHIT alterations in carcinogenesis remains unclear, as alterations of FHIT transcripts also occur in non-neoplastic tissues. 33 In contrast to other studies reporting frequent LOH at 3p24-26 (VHL, PPARg) in 64% of the cases, 19 we found only 4 cases (15%) with LOH in this region. The frequency of 41% gains on 20q13 is similar to our own published data (33%) 7 acquired from aCGH, and an amplification of MYC (8q24) in 30% of the cases is comparable to previous studies, Genomic regions with common LOH in at least 19% (5/27) of the cases were detected by LOH scoring. In each row below, frequency and type of alteration is written in italics when detected by matched pair analysis. On the right, the least common LOH regions are listed with candidate genes, which are referenced when known to be altered in BCA. reporting a MYC amplification in 25% of high-grade dysplasias and 44% of adenocarcinomas. 17 There was no significant correlation of genomic alterations with tumor stage and histological grading. However, this does not exclude an association between genomic instability and tumor progression as the number of investigated cases in this study was limited.
We also observed many other alterations that have not been described in Barrett's adenocarcinoma so far. The anaplastic lymphoma kinase (ALK), involved in the t(2;5) chromosomal rearrangement in anaplastic large cell lymphoma, has been found to be activated due to amplification in neuroblastoma. 34 Although gene amplification of ALK in esophageal carcinomas has not been reported to date, we found a low-level DNA gain at the ALK locus in 44% of the cases. As ALK expression can be detected in several tumor cell lines, Dirks et al 35 conclude that ALK expression may be a physiologic rather than a pathologic phenomenon. However, activation of ALK due to low-level copy-number gains could be relevant also in initiation and progression of carcinomas.
Another novel low-level DNA gain was seen on 3q27.1 (30% of the cases), harboring genes such as MUC13, coding a transmembrane protein, which is reported to be overexpressed in intestinal-type gastric cancer 36 and showed a trend toward higher expression in esophageal adenocarcinomas compared with normal tissue. 15 The highest copy numbers were detected in two regions of chromosome 8: amplification of 8q24/MYC (30%) with up to 19.7 copies per cell and the amplicon on 8p23 (26%) with up to 21.5 copies per cell, involving several candidate genes, such as GATA4 37 and the gene coding the transcription factor SOX7, as confirmed by FISH analysis. Slight discrepancy in Genetic alterations in Barrett's carcinoma T Wiech et al the copy numbers of distinct genes between the array and FISH analyses could be due to the well-recognized heterogeneity of Barrett's carcinoma, 38 as paraffin sections from different levels of a tumor block have been used for the two techniques. However, although we used rather pure microdissected tumor cell populations with a tumor content of at least 70% for SNP analysis, low copy-number changes may have been missed by contaminating non-neoplastic cells. On the other hand, FISH analysis may fail to detect low copynumber changes because a portion of cell nuclei in the tissue sections are incomplete. SOX7, which is upregulated in pancreatic cancer cell lines and in primary gastric cancer, 39 plays a role in parietal endoderm differentiation 40 and is a potent activator of transcription of the proto-oncogene Fgf-3 41 and interacts with the Wnt signaling pathway. 42 A frequent loss (36%) 4 and LOH (45%) 19 on 5q have been described in esophageal adenocarcinoma before. Here, 18% (score) and 36% (matched pair analysis) of our cases showed an LOH at 5q, where the candidate genes APC, MCC and IRF-1 are located. As mutations of the retained allele of APC in Barrett's adenocarcinoma 43 and of MCC in gastric cancer 44 are not very frequent, there may be another target gene on 5q, such as IRF-1, which can induce apoptosis of esophageal adenocarcinoma cells in vitro. 45 However, the least common LOH area (score) in our study was 5q32-5q35.1, harboring genes such as ECRG2, a candidate of tumor suppressor gene in esophageal squamous cell carcinoma. 28 Allelic losses of the chromosome arm 7q in Barrett's adenocarcinoma are reported in 33%. 5 Vissers et al 29 describe frequent allelic losses in the distal part of 7q, including the marker D7S483, which may aid to distinguish between esophageal (Barrett's) and gastric cardia carcinomas. In our study, 19% by scoring and 36% of the carcinomas in matched pair analysis showed an LOH of 7q. Four cases had a deletion of the whole chromosome arm and one carcinoma showed a distal deletion 7q35-qter.
Mutation or loss of cadherin (CDH) genes have been described to occur in several carcinomas, such as E-cadherin (CDH1) mutations in familial gastric cancer 46 and lobular breast cancer. 47 A copy-number loss of 18q21.33, the location of CDH20, could be detected in 41% of the cases in our study, and LOH was observed in 26% (score) to 36% (matched pairs), which could point to a possible involvement of adhesion molecules in the progression of esophageal adenocarcinoma.
Whereas LOH on 6p has been reported to occur frequently in some other carcinomas, such as esophageal squamous cell carcinoma 48 and gastric adenocarcinoma, 49 it has not been described in esophageal adenocarcinoma. Here, 19% (score) to 36% (matched pairs) of our cases had an LOH on 6p with some variance in the extent and location of the LOH regions. However, regarding the least common LOH region on 6p22.1 (28 575-29 359 Mb), candidate genes such as TRIM27, ZNF452 and ZNF311, as well as genes coding for glutathione peroxidases-5 and -6 (GPX5 and GPX6) are to be considered. As chronic gastroesophageal reflux disease as a known risk factor for intestinal metaplasia induces oxidative stress, a loss of expression of antioxidant enzymes such as GPX5 and GPX6 could increase mucosal damage. Reduced expression of these enzymes has not been described in esophageal adenocarcinoma up to now, but hypermethylation and loss of expression of another glutathione peroxidase (GPX3) could be detected in Barrett's tumorigenesis. 50 In copy-number analysis, losses on 9p21 and 9p22 were found in 59 (IFNA1) and 44% (p16) of the cases, which is comparable to published CGH studies, showing admittedly great variance in frequency (17-53%). 4, 51 Interestingly, in our study only 21% of the cases revealed LOH on 9p as detected by LOH score in contrast to published higher frequencies of LOH studies (35-75%) . 21, 24 This may be due to lower sensitivity of the LOH detection algorithm compared to copynumber analysis or other LOH detection techniques. Including manual matched pair analysis increased the LOH frequency to a proportion of 64% of the cases, which is more consistent with previous studies.
In conclusion, our results of DNA copy-number changes and LOH in Barrett's adenocarcinoma are relatively concordant with published data using other techniques such as CGH and PCR, and could partly be confirmed by FISH. Hence, SNP array technology is a valuable tool with the opportunity of genome-wide parallel analysis of copy-number gains, losses and LOH, especially if matched pair analysis is performed to reveal smaller LOH regions.
